Romania for up to 30 days per year. Conditions apply. Please contact HR for support. Health and sport: Medical... subscription - We know how important health is, so you get a medical subscription through the Regina Maria network, paid by the...
Reprezentant medical – Cluj Responsabilitati Reprezintă imaginea companiei și implementează strategia de vânzări..., conferințe, expoziții etc.). Cerinte Experiență în vânzări, de preferință în domeniul medical; Orientarea către client...
like the perfect job? We've got even more to offer: Work from Home- Hybrid approach Medical and dental services Life..., medical condition, HIV status, social origin, cultural background, social or marital status. Worried that you don't meet...
applicants will receive consideration for employment without regard to age, ancestry, color, family or medical care leave, gender... identity or expression, genetic information, marital status, medical condition, national origin, physical or mental disability...
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »
V-Mart acquired Limeroad in FY23 to push its omnichannel strategy, but has been cutting costs to reduce Limeroad’s losses of late..Limeroad’s Ebitda loss in FY24 stood at ₹71.6 crore and V-Mart expects the FY25 loss to be 40-50% of that. Continue Reading »